UMMS Affiliation

Department of Medicine, Division of Hospital Medicine

Publication Date

2020-04-14

Document Type

Article Postprint

Disciplines

Cardiology | Cardiovascular Diseases | Infectious Disease | Virus Diseases

Abstract

We read with much interest the article “Are certain drugs associated with enhanced mortality in COVID -19” by Goldstein et al your esteemed Journal. Authors have discussed the theoretical basis of angiotensin receptor blockers, statins in worsening outcome of COVID – 19 patients.(1) We believe that this topic is rapidly evolving and requires further evidence and discussion for understanding the multiple factors which contribute to the pathogenesis and outcome. We have the following comments.

Keywords

cardiac drugs, COVID-19, coronavirus, mortality, angiotensin receptor blockers, pathogenesis, letter to the editor

Rights and Permissions

© The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. Accepted manuscript posted after 12 months as allowed by publisher's self-archiving policy at https://academic.oup.com/journals/pages/self_archiving_policy_b

DOI of Published Version

10.1093/qjmed/hcaa127

Source

Mishra AK, Sahu KK, Sargent J. Cardiac drugs and outcome in COVID - 19. QJM. 2020 Apr 14:hcaa127. doi: 10.1093/qjmed/hcaa127. Epub ahead of print. PMID: 32289168. Link to article on publisher's site

Journal/Book/Conference Title

QJM : monthly journal of the Association of Physicians

Related Resources

Link to Article in PubMed

PubMed ID

32289168

Available for download on Wednesday, April 14, 2021

Share

COinS